← Back to Clinical Trials
Recruiting NCT02728479
NCT02728479 Percutaneous Transluminal Angioplasty Registry
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT02728479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Klinik für Kardiologie, Pneumologie und Angiologie |
| Condition | Percutaneous Transluminal Angioplasty |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2014-01 |
| Primary Completion | 2030-01 |
Trial Parameters
Condition Percutaneous Transluminal Angioplasty
Sponsor Klinik für Kardiologie, Pneumologie und Angiologie
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-01
Completion 2030-01
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing PTA Exclusion Criteria: * \< 18 years
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology